Moscow, Russia

Lia Vladimirovna Epishina


Average Co-Inventor Count = 12.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1976-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lia Vladimirovna Epishina: Innovator in Medicinal Chemistry

Introduction

Lia Vladimirovna Epishina is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating ischemic heart disease. With a total of 3 patents, her work has garnered attention in both academic and pharmaceutical circles.

Latest Patents

One of her latest patents is an antianginal medicated compound that comprises the active principle 2,4,6,8-tetramethyl-2,4,6,8-tetraazobicyclo-[3.3.0]-octanedione-3,7. This compound is designed to be used in combination with a pharmaceutical carrier, providing a new avenue for the treatment of patients suffering from ischemic heart disease. Another notable patent involves a pharmaceutical composition for use in psychic disorders, which contains the same active ingredient, showcasing her versatility in medicinal applications.

Career Highlights

Throughout her career, Lia has worked with esteemed institutions, including the Institute of Organic Chemistry named after N.D. Zelinsky of the Academy of Sciences of the USSR. Her research has been pivotal in advancing the understanding and treatment of various medical conditions.

Collaborations

Lia has collaborated with notable colleagues such as Lenor Ivanovich Khmelnitsky and Oleg Vasilievich Lebedev. Their combined expertise has contributed to the successful development of innovative medicinal compounds.

Conclusion

Lia Vladimirovna Epishina stands out as a significant figure in the field of medicinal chemistry, with her innovative patents paving the way for advancements in treatment options. Her contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…